Academic article

• Barnes, Daniel R.; Tyrer, Jonathan P.; Dennis, Joe et al. (2025). Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer. (external link)
• Dybedal, Ingunn; Iversen, Nina; Jacobsen, Anne Flem et al. (2025). Hereditary antithrombin deficiency and venous thrombosis in pregnancy–results of a retrospective multicenter study. (external link)
• Abrantes, Rafaela; Forcados, Christopher; Warren, David et al. (2025). Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors. (external link)
• Tandaric, Luka; Auranen, Annika; Kleinmanns, Katrin et al. (2025). Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in arm A of the NSGO-OV-UMB1/ENGOT-OV30 trial. (external link)
• Mirza, Mansoor R.; Bjørge, Line; Marmé, Frederik et al. (2025). Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial. (external link)
• Vistad, Ingvild; Skorstad, Mette; Berntsen, Sveinung et al. (2025). Empowerment and quality of life in gynecological cancer survivors: Outcomes from a multicenter quasi-experimental cohort study from Norway (the LETSGO trial). (external link)
• Perez-Fidalgo, Alejandro; Schmalfeldt, Barbara; George, Angela et al. (2024). Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer. (external link)
• Gissum, Karen; Drageset, Sigrunn; Thomsen, Liv Cecilie Vestrheim et al. (2024). Navigating the Complexities of Ovarian Cancer Care: Perspectives from Nurses. (external link)
• Kjeldsen, Maj K.; Jørgensen, Morten; Grønseth, Dina Sofie B et al. (2024). Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer. (external link)
• Dareng, Eileen O.; Coetzee, Simon G.; Tyrer, Jonathan P. et al. (2024). Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. (external link)
• Solheim, Eirik Tveit; Thomsen, Liv Cecilie Vestrheim; Bjørge, Line et al. (2024). Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration. (external link)
• Bischof, Katharina; Cremaschi, Andrea; Eroukhmanoff, Lena et al. (2024). Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways. (external link)
• Mirza, M.R.; Tandaric, Luka; Henriksen, J.R. et al. (2024). NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer. (external link)
• Casey, Nicholas Paul; Kleinmanns, Katrin; Forcados, Christopher et al. (2024). Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16. (external link)
• Torkildsen, Cecilie Fredvik; Austdal, Marie; Jarmund, Anders Hagen et al. (2024). New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients. (external link)
• Powell, M.A.; Bjørge, Line; Willmott, L. et al. (2024). Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial. (external link)
• Ramachandran, Dhanya; Tyrer, Jonathan P.; Kommoss, Stefan et al. (2024). Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease. (external link)
• Puco, Katarina; Fagereng, Gro Live; Brabrand, Sigmund et al. (2024). IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results. (external link)
• Vilming, Bente; Dahl, Jørgen Fallås; Bentzen, Anne Gry et al. (2023). Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer. (external link)
• Torkildsen, Cecilie Fredvik; Thomsen, Liv Cecilie Vestrheim; Sande, Ragnar et al. (2023). Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. (external link)
• Torkildsen, Cecilie Fredvik; Austdal, Marie; Iversen, Ann-Charlotte et al. (2023). Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins. (external link)
• May, Taymaa; Bernardini, Marcus; Lheureux, Stephanie et al. (2023). Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis. (external link)
• Oaknin, Ana; Gladieff, Laurence; Martínez-García, Jerónimo et al. (2023). Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial. (external link)
• Dongre, Harsh Nitin; Elnour, Rammah; Tornaas, Stian et al. (2023). TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma. (external link)
• Haugan, Hanne Marie; Bjørge, Line; Løkeland-Stai, Mette (2023). Nemndabort 1979–2022 – hva har skjedd?. (external link)
• Thomsen, Liv Cecilie Vestrheim; Kleinmanns, Katrin; Anandan, Shamundeeswari et al. (2023). Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study. (external link)
• Bjørge, Tone; Hjellvik, Vidar; Bjørge, Line et al. (2023). Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study. (external link)
• Barrett, James E.; Jones, Allison; Evans, Iona et al. (2022). The WID-EC test for the detection and risk prediction of endometrial cancer. (external link)
• Mundal, Siv Boon; Rakner, Johanne Johnsen; Silva, Gabriela et al. (2022). Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction. (external link)
• Barrett, James E.; Herzog, Chiara; Kim, Yoo-Na et al. (2022). Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock. (external link)
• Perrone, Maria Grazia; Vitale, Paola; Miciaccia, Morena et al. (2022). Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes. (external link)
• Dareng, Eileen O.; Tyrer, Jonathan P.; Barnes, Daniel R. et al. (2022). Polygenic risk modeling for prediction of epithelial ovarian cancer risk. (external link)
• Kleinmanns, Katrin; Gullaksen, Stein-Erik; Bredholt, Geir et al. (2022). Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies. (external link)
• Wohlmuth, Christoph; Djedovic, Vladimir; Kjær, Susanne K. et al. (2022). CA-125 levels are predictive of survival in low-grade serous ovarian cancer—A multicenter analysis. (external link)
• Madland, Karen; Bjørge, Line; Småstuen, Milada Cvancarova et al. (2022). Symptomatic or asymptomatic recurrence of ovarian cancer: does it influence survival?. (external link)
• Gissum, Karen Rosnes; Drageset, Sigrunn; Thomsen, Liv Cecilie Vestrheim et al. (2022). Living With Ovarian Cancer: Transitions Lost in Translation. (external link)
• Barrett, James E.; Jones, Allison; Evans, Iona et al. (2022). The DNA methylome of cervical cells can predict the presence of ovarian cancer. (external link)
• Barrett, James E.; Herzog, Chiara; Jones, Allison et al. (2022). The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples. (external link)
• Herzog, Chiara; Marín, Fátima; Jones, Allison et al. (2022). A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets. (external link)
• Jalón, Elvira García de; Kleinmanns, Katrin; Fosse, Vibeke Samuelsen et al. (2021). Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model. (external link)
• Quinn, Michael C.J.; McCue, Karen; Shi, Wei et al. (2021). Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer. (external link)
• Rakner, Johanne Johnsen; Silva, Gabriela; Mundal, Siv Boon et al. (2021). Decidual and placental NOD1 is associated with inflammation in normal and preeclamptic pregnancies. (external link)
• Anandan, Shamundeeswari; Thomsen, Liv Cecilie Vestrheim; Gullaksen, Stein-Erik et al. (2021). Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods. (external link)
• Glubb, Dylan M.; Thompson, Deborah J.; Aben, Katja K H et al. (2021). Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers. (external link)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (external link)
• Nené, Nuno R.; Barrett, James; Jones, Allison et al. (2020). DNA methylation signatures to predict the cervicovaginal microbiome status. (external link)
• Engerud, Hilde Renate; Berg, Hege Fredriksen; Myrvold, Madeleine et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (external link)
• Kleinmanns, Katrin; Bischof, Katharina; Anandan, Shamundeeswari et al. (2020). CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma. (external link)
• Fonnes, Tina; Strand, Elin; Fasmer, Kristine Eldevik et al. (2020). Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. (external link)
• Dongre, Harsh; Rana, Neha; Fromreide, Siren et al. (2020). Establishment of a novel cancer cell line derived from vulvar carcinoma associated with lichen sclerosus exhibiting a fibroblast-dependent tumorigenic potential. (external link)
• Kleinmanns, Katrin; Fosse, Vibeke Samuelsen; Davidson, Ben et al. (2020). CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model. (external link)
• Silva, Gabriela; Gierman, Lobke; Rakner, Johanne Johnsen et al. (2020). Cholesterol crystals and NLRP3 mediated inflammation in the uterine wall decidua in normal and preeclamptic pregnancies. (external link)
• Grant, Delores J.; Manichaikul, Ani; Alberg, Anthony J. et al. (2019). Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American women. (external link)
• Jiang, Xia; Finucane, Hilary K.; Schumacher, Fredrick R. et al. (2019). Shared heritability and functional enrichment across six solid cancers. (external link)
• Mirza, Mansoor Raza; Bergmann, Troels K.; Mau-Sørensen, Morten et al. (2019). A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24. (external link)
• Nené, Nuno R.; Reisel, Daniel; Leimbach, Andreas et al. (2019). Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. (external link)
• Bischof, Katharina; Knappskog, Stian; Hjelle, Sigrun Margrethe et al. (2019). Influence of p53 isoform expression on survival in high-grade serous ovarian cancers. (external link)
• Mirza, Mansoor Raza; Lundqvist, Elisabeth Åvall; Birrer, Michael J. et al. (2019). Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial. (external link)
• Kristoffersen, Ann-Helen; Petersen, Per Hyltoft; Bjørge, Line et al. (2019). Concentration of fibrin monomer in pregnancy and during the postpartum period. (external link)
• Yang, Yaohua; Wu, Lang; Shu, Xiang et al. (2019). Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. (external link)
• Ray-Coquard, Isabelle; Cibula, David; Mirza, Mansoor R. et al. (2019). Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer. (external link)
• Austdal, Marie; Silva, Gabriela; Bowe, Sophie et al. (2019). Metabolomics identifies placental dysfunction and confirms Flt-1 (FMS-like tyrosine kinase receptor 1) biomarker specificity. (external link)
• Earp, Madalene; Tyrer, Jonathan P.; Winham, Stacey J. et al. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. (external link)
• Kristoffersen, Ann-Helen; Petersen, Per Hyltoft; Bjørge, Line et al. (2018). Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women. (external link)
• Dixon-Suen, Suzanne C.; Nagle, Christina M; Thrift, Aaron P. et al. (2018). Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study. (external link)
• Tangerås, Line Haugstad; Silva, Gabriela; Stødle, Guro et al. (2018). Placental inflammation by HMGB1 activation of TLR4 at the syncytium. (external link)
• Kelemen, Linda E.; Earp, Madalene; Fridley, Brooke L. et al. (2018). rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology. (external link)
• Stødle, Guro; Silva, Gabriela; Tangerås, Line Haugstad et al. (2018). Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. (external link)
• Bischof, Katharina; Knappskog, Stian; Stefansson, Ingunn et al. (2018). High expression of the p53 isoform ? is associated with reduced progression-free survival in uterine serous carcinoma. (external link)
• Fasmer, Kristine Eldevik; Bjørnerud, Atle; Ytre-Hauge, Sigmund et al. (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. (external link)
• Fonnes, Tina; Trovik, Jone; Edqvist, Per-Henrik D. et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (external link)
• Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018). A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. (external link)
• Lønning, Per Eystein; Berge, Elisabet Ognedal; Bjørnslett, Merete Pauline et al. (2018). White blood cell BRCA1 promoter methylation status and ovarian cancer risk. (external link)
• Ytre-Hauge, Sigmund; Dybvik, Julie Andrea; Lundervold, Arvid et al. (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. (external link)
• Landskron, Johannes; Kraggerud, Sigrid M.; Wik, Elisabeth et al. (2017). C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease. (external link)
• Phelan, Catherine M.; Kuchenbaecker, Karoline B.; Tyrer, Jonathan P. et al. (2017). Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. (external link)
• Mauland, Karen Klepsland; Ju, Zhenlin; Tangen, Ingvild Løberg et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (external link)
• Berg, Anna; Gulati, Ankush; Ytre-Hauge, Sigmund et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (external link)
• Tangen, Ingvild Løberg; Kopperud, Reidun Kristin; Visser, Nicole C.M. et al. (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. (external link)
• Ytre-Hauge, Sigmund; Esmaeili, Morteza; Sjøbakk, Torill Eidhammer et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (external link)
• Njølstad, Tormund Salvesen; Werner, Henrica Maria Johanna; Marcickiewicz, Janusz et al. (2017). Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study. (external link)
• Vistad, Ingvild; Bjørge, Line; Popova, Olesya et al. (2017). A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway. (external link)
• Glubb, Dylan M.; Johnatty, Sharon E.; Quinn, Michael C.J. et al. (2017). Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. (external link)
• Bois, Andreas du; Kristensen, Gunnar S Balle; Ray-Coquard, Isabelle et al. (2016). Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): A randomised, double-blind, placebo-controlled phase 3 trial. (external link)
• Dixon, Suzanne C.; Nagle, Christina M; Thrift, AG et al. (2016). Adult body-mass index and ovarian cancer risk by subtype: A Mendelian randomization study. (external link)
• Hampras, Shalaka S.; Sucheston-Campbell, Lara E.; Cannioto, Rikki et al. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. (external link)
• Gibson, William J.; Høivik, Erling Andre; Halle, Mari Kyllesø et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (external link)
• Thomsen, Liv Cecilie Vestrheim; McCarthy, Nina; Melton, Philip E. et al. (2016). The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia. (external link)
• Cuellar-Partida, Gabriel; Lu, Yi; Dixon, Suzanne C. et al. (2016). Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. (external link)
• Permuth, Jennifer B.; Reid, Brett; Earp, Madalene et al. (2016). Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: Results from a large-scale collaboration. (external link)
• Ong, Jue-Sheng; Cuellar-Partida, Gabriel; Lu, Yi et al. (2016). Association of vitamin D levels and risk of ovarian cancer: A Mendelian randomization study. (external link)
• Helland, Øystein; Popa, Mihaela Lucia; Bischof, Katharina et al. (2016). The HDACi panobinostat shows growth inhibition both in vitro and in a bioluminescent orthotopic surgical xenograft model of ovarian cancer. (external link)
• Hveem, Tarjei Sveinsgjerd; Njølstad, Tormund Salvesen; Nielsen, Birgitte et al. (2016). Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer. (external link)
• Liang, Dong; Hildebrant, Michelle A T; Ness, Roberta B et al. (2016). BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (external link)
• Bjørge, Tone; Skare, Gry Baadstrand; Bjørge, Line et al. (2016). Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia. (external link)
• Løkeland, Mette; Bjørge, Tone; Iversen, Ole-Erik et al. (2016). Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013. (external link)
• Lawrenson, Kate; Kar, Siddhartha; McCue, Karen et al. (2016). Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. (external link)
• Southey, Melissa C; Goldgar, David E; Winqvist, Robert et al. (2016). PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS. (external link)
• Berg, Anna; Fasmer, Kristine Eldevik; Mauland, Karen Klepsland et al. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. (external link)
• Ytre-Hauge, Sigmund; Husby, Jenny Hild Aase; Magnussen, Inger Johanne et al. (2015). Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. (external link)
• Kelemen, Linda E.; Lawrenson, Kate; Tyrer, Jonathan et al. (2015). Genome-wide significant risk associations for mucinous ovarian carcinoma. (external link)
• Lee, Alice W.; Tyrer, Jonathan P; Doherty, Jennifer A et al. (2015). Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study. (external link)
• Lawrenson, Kate; Iversen, Edwin S.; Tyrer, Jonathan et al. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. (external link)
• Chornokur, Ganna; Lin, Hui-Yi; Tyrer, Jonathan P. et al. (2015). Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. (external link)
• Kar, Siddhartha P.; Tyrer, Jonathan P.; Li, Qiyuan et al. (2015). Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. (external link)
• Lu, Yi; Cuellar-Partida, Gabriel; Painter, Jodie N. et al. (2015). Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. (external link)
• Roten, Linda Tømmerdal; Thomsen, Liv Cecilie Vestrheim; Gundersen, Astrid et al. (2015). The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes. (external link)
• Thomsen, Liv Cecilie Vestrheim; Melton, Philip E.; Tollaksen, Kjersti et al. (2015). Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. (external link)
• Landskron, Johannes; Helland, Øystein; Torgersen, Knut Martin et al. (2015). Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. (external link)
• Lawrenson, Kate; Li, Qiyuan; Kar, Siddhartha et al. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. (external link)
• Husby, Jenny Hild Aase; Salvesen, Øyvind; Magnussen, Inger Johanne et al. (2015). Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. (external link)
• Amankwah, Ernest K.; Lin, Hui-Yi; Tyrer, Jonathan P. et al. (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. (external link)
• Austdal, Marie; Thomsen, Liv Cecilie Vestrheim; Tangerås, Line Haugstad et al. (2015). Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. (external link)
• Husby, Jenny Hild Aase; Reitan, Bernt Christian; Biermann, Martin et al. (2015). Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. (external link)
• Kuchenbäcker, Karoline B.; Ramus, Susan J.; Tyrer, Jonathan et al. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. (external link)
• Haldorsen, Ingfrid S.; Stefansson, Ingunn; Grüner, Renate et al. (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. (external link)
• Helland, Øystein; Popa, Mihaela Lucia; Vintermyr, Olav Karsten et al. (2014). First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma. (external link)
• Earp, Magdalene A; Kelemen, Linda E.; Magliocco, Anthony M. et al. (2014). Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. (external link)
• Ojesina, Akinyemi; Lichtenstein, Lee; Freeman, Samuel S. et al. (2014). Landscape of genomic alterations in cervical carcinomas. (external link)
• Løkeland, Mette; Iversen, Ole-Erik; Engeland, Anders et al. (2014). Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation. (external link)
• Kelemen, Linda E.; Terry, Kathryn L.; Goodman, Marc T. et al. (2014). Consortium analysis of diet-gene interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.. (external link)
• Landskron, Johannes; Helland, Øystein; Torgersen, Knut Martin et al. (2014). Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. (external link)
• Thomsen, Liv Cecilie Vestrheim; Melve, Kari Klungsøyr; Roten, Linda Tømmerdal et al. (2013). Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway. (external link)
• Macsali, Ferenc; Svanes, Cecilie; Sothern, R. B. et al. (2013). Menstrual Cycle and Respiratory Symptoms in a General Nordic-Baltic Population. (external link)
• Haldorsen, Ingfrid S.; Grüner, Renate; Husby, Jenny Hild Aase et al. (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. (external link)
• Thomsen, Liv Cecilie Vestrheim; Roten, Linda Tømmerdal; Klungsøyr, Kari et al. (2013). Validity of pre-eclampsia diagnosis in Medical Birth Registry of Norway. (external link)
• Baste, Valborg; Moen, Bente Elisabeth; Oftedal, Gunnhild et al. (2012). Pregnancy outcomes after paternal radiofrequency field exposure aboard fast patrol boats. (external link)
• Iversen, Grete Alræk; Løkeland, Mette; Fjereide, Anneli Kathrine et al. (2012). Er det mulig å få pålitelig kunnskap om psykiske senvirkninger etter provosert abort?. (external link)
• Møllerløkken, Ole Jacob; Moen, Bente Elisabeth; Baste, Valborg et al. (2012). No effects of MRI scan on male reproduction hormones. (external link)
• Lian, Ingrid Alsos; Løset, Mari; Mundal, Siv Boon et al. (2011). Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. (external link)
• Løset, Mari; Mundal, Siv Boon; Johnson, Matthew et al. (2011). A transcriptional profile of the decidua in preeclampsia. (external link)
• Johansson, Åsa; Curran, Joanne E; Johnson, Matthew p. et al. (2011). Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. (external link)
• Lian, Ingrid Alsos; Toft, Johanne Holm; Olsen, Guro Dalheim et al. (2010). Matrix Metalloproteinase 1 in Pre-eclampsia and Fetal Growth Restriction: Reduced Gene Expression in Decidual Tissue and Protein Expression in Extravillous Trophoblasts. (external link)
• Fenstad, Mona Høysæter; Johnson, Matthew; Løset, Mari et al. (2010). STOX2 but not STOX1 is differently expressed in preeclampstic decidua from Norwegian women: data from the Second Nord-Trondelag Health Study. (external link)
• Løkeland, Mette; Iversen, Ole-Erik; Dahle, Gunhild Svanes et al. (2010). Medical Abortion at 63 to 90 Days of Gestation. (external link)
• Macsali, Ferenc; Real, Francisco Gomez; Omenaas, Ernst et al. (2009). Oral contraception, body mass index, and asthma: A cross-sectional Nordic-Baltic population survey. (external link)
• Toft, Johanne Holm; Lian, Ingrid Alsos; Tarca, AL et al. (2008). Whole-genome microarray and targeted placental analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PIGF) from pre-eclamptic and small-for-gegstational-age pregnancies. (external link)
• Bjørge, Line; Stoiber, Heribert; Meri, Seppo (2006). Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy. (external link)
• Harboe, Torkel; Benson, Michael D.; Oi, Hanaku et al. (2006). Cardiopulmonary distress during obstetrical anaesthesia: attempts to diagnose amniotic fluid embolism in a case series of suspected allergic anaphylaxis. (external link)
• Bjørge, Line; Stoiber, Heribert; Dierich, Manfred P. et al. (2006). Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy. (external link)
• Kristoffersen, Einar Klæboe; Haram, Kjell; Edvardsen, Britt et al. (2006). Placental expression of glycophosphatidylinositol (GPI)-anchored proteins in paroxysmal nocturnal haemoglobinuria. (external link)
• Bjørge, Line; Hakulinen, Jaakku; Vintermyr, Olav Karsten et al. (2005). Ascitic complement system in ovarian cancer. (external link)

Academic lecture

• Jarmund, Anders Hagen; Svoren, Åse Turid Rossevatn; Rakner, Johanne Johnsen et al. (2025). Distinkte sykdomsprosesser i placenta, decidua og serum hos mor ved preeklampsi med og uten føtal veksthemming. (external link)
• Jarmund, Anders Hagen; Giskeødegård, Guro F.; Ryssdal, Mariell et al. (2023). Decoding the immune and lipid landscape of preeclampsia: A study of disease subtypes and activity. (external link)
• Gjerde, Christiane Helgestad; Langer, Anika; Garibay, Gorka Ruiz de et al. (2022). Establishment of ovarian cancer organoids on peritoneal dECM scaffolds. (external link)
• Gjerde, Christiane Helgestad; Langer, Anika; Garibay, Gorka Ruiz de et al. (2022). Establishment of peritoneal dECM scaffolds for culture of ovarian cancer organoids. (external link)
• Rakner, Johanne Johnsen; Silva, Gabriela; Elschot, Mattijs et al. (2021). The link between inflammatory and vascular pathology and sFlt-1 expression at the maternal-fetal interface in preeclampsia. (external link)
• Gissum, Karen Rosnes; Bjørge, Line; Strand, Roger (2021). Between Illness and Disease: Ovarian Cancer Lost in Translation. (external link)
• Rakner, Johanne Johnsen; Silva, Gabriela; Elschot, Mattijs et al. (2021). The link between sFlt-1 expression and inflammatory and vascular pathology at the maternal-fetal interface in preeclampsia. (external link)
• Jarmund, Anders Hagen; Giskeødegård, Guro F.; Rakner, Johanne Johnsen et al. (2021). Systemic immunological perturbations and placental pathology in preeclampsia. (external link)
• Gjerde, Christiane Helgestad; Garibay, Gorka Ruiz de; Mccormack, Emmet Matin et al. (2020). Rethinking ovarian cancer: Establishment of an organoid-based preclinical platform for ovarian cancer.. (external link)
• Gissum, Karen Rosnes; Bjørge, Line (2019). What you should know about tumor reductive surgery in advanced ovarian cancer – Clinical recommendations from a patient perspective. (external link)
• Mundal, Siv Boon; Silva, Gabriela; Stødle, Guro et al. (2018). Decidual inflammation in normal and preeclamptic pregnancies. (external link)
• Mundal, Siv Boon; Basnet, Purusotam; Silva, Gabriela et al. (2016). Decidual Nrf2-mediated oxidative stress response in preeclampsia and fetal growth restriction. (external link)
• Silva, Gabriela; Tangerås, Line Haugstad; Stødle, Guro et al. (2015). The inflammatory role of HMGB1 in preeclampsia. (external link)
• Iversen, Ann-Charlotte; Bjørge, Line (2013). Preeclampsia and cardiovascular disease - shared causative genetic mechanisms?. (external link)
• Roten, Linda Tømmerdal; Johnson, Matthew; Thomsen, Liv Cecilie Vestrheim et al. (2013). A preeclampsia genome-wide linkage scan in Norwegian families. (external link)
• Thomsen, Liv Cecilie Vestrheim; Melton, Philip E.; Sun, Chen et al. (2013). Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. (external link)
• Løkeland, Mette; Iversen, Ole-Erik; Bjørge, Line (2011). MEDICAL ABORTION WITH HOME ADMINISTRATION OF MISOPROSTOL UP TO 63 DAYS GESTATION. (external link)
• Lian, Ingrid Alsos; Løset, Mari; Mundal, Siv Boon et al. (2010). Endoplasmic reticulum stress in decidual tissue from pregnancies complicated by pre-eclampsia. (external link)
• Løkeland, Mette; Bjørge, Line (2010). Norway: In transition from surgical to medical termination. (external link)
• Løkeland, Mette; Bjørge, Line (2008). Women's choices: Why do they opt for medical abortion?. (external link)

Poster

• Jarmund, Anders Hagen; Rakner, Johanne Johnsen; Svoren, Åse Turid Rossevatn et al. (2025). sFlt-1 at the maternal-fetal interface and in maternal serum is not coregulated and show divergent upregulation in preeclampsia subtypes. (external link)
• Jarmund, Anders Hagen; Svoren, Åse Turid Rossevatn; Buer, Signe Haaland et al. (2023). Immune deviation and dyslipidemia in diagnosed preeclampsia. (external link)
• Gissum, Karen Rosnes; Drageset, Sigrunn; Thomsen, Liv Cecilie Vestrheim et al. (2022). Living with Ovarian Cancer: Transitions Lost in Translation. (external link)
• Gjerde, Christiane Helgestad; Langer, Anika; Garibay, Gorka Ruiz de et al. (2022). Establishment of peritoneal dECM scaffolds for 3D culture of ovarian cancer organoids. (external link)
• Gissum, Karen Rosnes; Drageset, Sigrunn; Thomsen, Liv Cecilie Vestrheim et al. (2022). Quality of Life of Patients with Ovarian Cancer: Biological Perspective Versus Patient Perspective. (external link)
• Gjerde, Christiane Helgestad; Langer, Anika; Garibay, Gorka Ruiz de et al. (2021). Establishment of ovarian cancer organoids on peritoneal dECM scaffolds. (external link)
• Gierman, Lobke; Silva, Gabriela; Pervaiz, Zahra et al. (2019). Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia. (external link)
• Gierman, Lobke; Silva, Gabriela; Pervaiz, Zahra et al. (2019). Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia. (external link)
• Kleinmanns, Katrin; Fosse, Vibeke Samuelsen; Davidson, Ben et al. (2019). EP889 improved cytoreduction of ovarian cancer using CD24 targeted fluorescence image guided surgery in a preclinical murine model. (external link)
• Gissum, Karen Rosnes; Drageset, Sigrunn; Vistad, Ingvild et al. (2019). What you should know about tumor reductive surgery in advanced ovarian cancer – Clinical recommendations from a patient perspective. (external link)
• Austdal, Marie; Silva, Gabriela Brettas; Bowe, Sophie et al. (2019). Metabolomics identifies placental dysfunction and confirms Flt-1 biomarker specificity.. (external link)
• Silva, Gabriela; Stødle, Guro; Gierman, Lobke et al. (2018). Inflammation at the uterine wall lining in pregnancy.. (external link)
• Pervaiz, Zahra; Gierman, Lobke; Silva, Gabriela et al. (2018). TLR3 expression and activation at the maternal-fetal interface in pregnancy. (external link)
• Kleinmanns, Katrin; Anandan, Shamundeeswari; Karlsen, Ida Tveit et al. (2017). Engraftement optimization, charaterization and tumor spread tracking by preclinical imaging in ovarian cancer patiant. (external link)
• Gierman, Lobke; Pervaiz, Zahra; Silva, Gabriela et al. (2017). An inflammatory role for TLR3 in decidua and placenta of normal and preeclamptic pregnancies. (external link)
• Gierman, Lobke; Stødle, Guro; Silva, Gabriela et al. (2016). NLRP3 inflammasome expression and activation at the maternal-fetal interface in preeclamptic and healthy pregnancies. (external link)
• Mundal, Siv Boon; Basnet, Purusotam; Silva, Gabriela et al. (2016). Nrf2-mediated oxidative stress response at the maternal-fetal interface in preeclampsia and fetal growth restriction. (external link)
• Pervaiz, Zahra; Gierman, Lobke; Silva, Gabriela et al. (2016). Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy. (external link)
• Stødle, Guro; Silva, Gabriela; Tangerås, Line Haugstad et al. (2015). The NLRP3 inflammasome in placentas from preeclamptic and healthy pregnancies. (external link)
• Tangerås, Line Haugstad; Gierman, Lobke; Stødle, Guro et al. (2015). The inflammatory role of HMGB1 in preeclamptic and normal pregnancies. (external link)
• Austdal, Marie; Thomsen, Liv Cecilie Vestrheim; Tangerås, Line et al. (2015). Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. (external link)
• Thomsen, Liv Cecilie Vestrheim; McCarthy, Nina; Melton, Philip E. et al. (2014). A genetic connection between preeclampsia and chronic hypertension in Norwegian families. (external link)
• Thomsen, Liv Cecilie Vestrheim; Melton, Philip E.; Tollaksen, Kjersti et al. (2014). Heritability of cardiovascular diseases in a preeclampsia family cohort. (external link)
• Helland, Øystein; Bishof, Katharina; Popa, Mihaela Lucia et al. (2013). Histone deacetylase inhibisjon i kombinasjon med platinum i en klinisk relevant ortotopisk musemodel for ovarialcancer. (external link)
• Helland, Øystein; Popa, Mihaela Lucia; Gjertsen, Bjørn Tore et al. (2013). Panobinostat / carboplatin delay postsurgical relapse of ovarian carcinomas in an orthotopic mouse model. (external link)
• Thomsen, Liv Cecilie Vestrheim; Melton, Philip E.; Tollaksen, Kjersti et al. (2013). Heritability of cardiovascular diseases in a preeclampsia family cohort. (external link)
• Thomsen, Liv Cecilie Vestrheim; Roten, Linda Tømmerdal; Iversen, Ann-Charlotte et al. (2012). A family based cohort study design to investigate genetic predisposition to preeclampsia and cardiovascular disease. The Norwegian Preeclampsia Family Study. (external link)
• Lian, Ingrid Alsos; Løset, Mari; Mundal, Siv Boon et al. (2011). Endoplasmic reticulum stress in decidual tissue from pregnancies complicated by pre-eclampsia and fetal growth restriction. (external link)
• Roten, Linda Tømmerdal; Thomsen, LCV; Gundersen, Astrid et al. (2011). Establishment of a Norwegian Preeclampsia Family Biobank. (external link)
• Ertzeid, Linda Grung; Økland, Ingrid; Bjørge, Line et al. (2010). Medical abortion between 9 and 12 weeks gestation. Experiences from a nursing perspective.. (external link)
• Gundersen, Astrid; Vestrheim, Liv Cecilie; Eide, Irina Poliakova et al. (2010). Biobanking of tissue and blood from pregnancies. (external link)
• Vestrheim, Liv Cecilie; Austgulen, Rigmor; Melve, Kari Klungsøyr et al. (2010). Classification of pre-eclamptic pregnancies in health registries. An evaluation of criteria selected and pregnancies included in the Medical Birth Registry of Norway. (external link)

Article in business/trade/industry journal

• Bjørge, Line (2024). Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup. (external link)
• Kleinmanns, Katrin; Bjørge, Line (2024). Prospects for precision medicine in ovarian cancer.. (external link)
• Helland, Åslaug; Russnes, Hege Elisabeth Giercksky; Fagereng, Gro Live et al. (2022). Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway. (external link)
• Jacobsen, Anne Flem; Kristiansen, Annette; Bjørge, Line et al. (2014). Antikoagulasjon ved venøs trombose i svangerskapet. (external link)

Academic literature review

• Trichkova, Kremena Petrova; Görtler, Franziska Stilla Maria; Bjørge, Line et al. (2024). Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors. (external link)
• Myhr, Andrea Svennevik; Bjørge, Line; Torkildsen, Cecilie Fredvik (2024). Secondary Cytoreductive Surgery in Relapsed Platinum-Sensitive Epithelial Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. (external link)
• Gierman, Lobke; Silva, Gabriela; Pervaiz, Zahra et al. (2020). TLR3 expression by maternal and fetal cells at the maternal-fetal interface in normal and preeclamptic pregnancies. (external link)
• Kleinmanns, Katrin; Fosse, Vibeke Samuelsen; Bjørge, Line et al. (2020). The emerging role of cd24 in cancer theranostics—a novel target for fluorescence image-guided surgery in ovarian cancer and beyond. (external link)
• Widschwendter, Martin; Jones, Allison; Evans, Iona et al. (2018). Epigenome-based cancer risk prediction: Rationale, opportunities and challenges. (external link)
• Hollestelle, Antoinette; Baan, Frederieke H Van Der; Berchuck, Andrew et al. (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (external link)
• Macsali, Ferenc; Svanes, Cecilie; Bjørge, Line et al. (2012). Respiratory health in women: from menarche to menopause. (external link)

Lecture

• Getz, Linn Okkenhaug; Engen, Caroline Benedicte Nitter; Bjørge, Line et al. (2023). Responsible clinical trials i the age of personalized medicine. (external link)
• Buer, Signe Haaland; Jarmund, Anders Hagen; Svoren, Åse Turid Rossevatn et al. (2023). Distinct immunological development throughout pregnancies complicated with preeclampsia, gestational hypertension, and chronic hypertension. (external link)
• Mundal, Siv Boon; Silva, Gabriela Brettas; Gierman, Lobke et al. (2019). Divergent regulation of decidual oxidative stress response in preeclampsia with and without fetal growth restriction. (external link)
• Silva, Gabriela Brettas; Gierman, Lobke; Stødle, Guro et al. (2019). The NLRP3 inflammasome expression by maternal and fetal cells in the uterine wall and association with preeclampsia development.. (external link)
• Silva, Gabriela Brettas; Gierman, Lobke; Stødle, Guro et al. (2019). NLRP3 inflammasome expression by maternal and fetal cells in decidua and its association with preeclampsia. (external link)
• Stødle, Guro; Silva, Gabriela; Tangerås, Line Haugstad et al. (2017). Inflammation in preeclampsia by NOD-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. (external link)
• Rakner, Johanne Johnsen; Gierman, Lobke; Silva, Gabriela et al. (2017). An inflammatory role for NOD1 in decidua and placenta of normal and preeclamptic pregnancies. (external link)
• Tangerås, Line; Stødle, Guro; Thomsen, Liv Cecilie Vestrheim et al. (2014). Inflammation in normal and preeclamptic pregnancies. (external link)

Feature article

• Nygård, Mari; Burger, Emily Annika; Nygård, Ståle et al. (2023). Skal vi screene og konisere inn i evigheten – eller bytte HPV-vaksine?. (external link)

Editorial

• Vistad, Ingvild; Bjørge, Line (2023). Advanced endometrial cancer: New medical treatment options on the horizon. (external link)

Errata

• Helland, Åslaug; Russnes, Hege Elisabeth Giercksky; Fagereng, Gro Live et al. (2022). Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5). (external link)
• Barrett, J. James E.; Herzog, Chiara; Kim, Yoo-Na et al. (2022). Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock (Genome Biology, (2022), 23, 1, (52), 10.1186/s13059-022-02603-3). (external link)
• Dareng, Eileen O.; Tyrer, Jonathan P.; Barnes, Daniel R. et al. (2022). Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362)). (external link)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (external link)
• Jiang, Xia; Finucane, Hilary K.; Schumacher, Fredrick et al. (2019). Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4). (external link)

Chapter

• Popa, Mihaela-Lucia; Fosse, Vibeke Samuelsen; Kleinmanns, Katrin et al. (2021). Xenograft Models of Ovarian Cancer for Therapy Evaluation. (external link)

Doctoral dissertation

• Costea, Daniela Elena; Bjørge, Line; Johannessen, Anne Christine et al. (2020). Biomarkers and preclinical models for more precise diagnosis and personalized treatment of oral and vulva carcinomas - Study on human samples and experimental models. (external link)
• Bischof, Katharina; Bjørge, Line; Gjertsen, Bjørn Tore et al. (2019). Rethinking Gynecological High- Grade Serous Carcinoma. Portraying the p53 isoform landscape and development of a new preclinical for optical imaging in xenograft models. (external link)
• Bjørge, Line (1996). Complement regulatory proteins in malignancies. (external link)

Academic chapter/article/Conference paper

• Kristoffersen, Einar Klæboe; Bjørge, Line (2007). Immunologi og reproduksjon. (external link)

See a complete overview of publications in Cristin.